What is CNCR?

CNCR tracks an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs.

PERFORMANCE [as of 03/29/23] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
CNCR -- -- -- -- -- -- --
CNCR (NAV) -9.07% -10.70% -11.45% -34.52% -11.73% -14.45% --
Loncar Cancer Immunotherapy Index -- -- -- -- -- -- --
MSCI USA IMI / Pharmaceuticals Biotechnology & Life Sciences -IG -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

CNCR Factset Analytics Insight

CNCR takes an approach to niche coverage within the health care sector. It provides equal-weighted exposure to about 30 companies of various sizes that have approved immunotherapy cancer drugs on the US or European markets or that are engaged in human clinical trials of such drugs. The fund seeks a holistic exposure to the immunotherapy space, specifically including companies with varying drug mechanisms. Equal-weighting of the securities draws attention to smaller companies with room to grow. This fund provides a unique option for investors placing a highly specialized bet on this space.

CNCR Summary Data

10/13/15
0.79%
$17.31M
MSCI USA IMI / Pharmaceuticals Biotechnology & Life Sciences -IG
Open-Ended Fund

Peers

MSCI USA IMI / Pharmaceuticals Biotechnology & Life Sciences -IG

Fund Flows

$0.00B 5 Days
$0.00B 30 Days
-$0.00B 90 Days

CNCR Portfolio Data

$26.42B
-11.46
2.96
13.46%
N/A
32

CNCR Index Data

Equal
Market Cap
MSCI USA IMI / Pharmaceuticals Biotechnology & Life Sciences -IG

CNCR Portfolio Management

0.79%
--
--
--

CNCR Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

CNCR Fund Structure

Open-Ended Fund
No
No
-- / --
N/A
N/A
High
Daily

Factset Analytics Block Liquidity

As of 03/30/23

This measurement shows how easy it is to trade a $1 million USD block of CNCR. CNCR is rated a 3 out of 5.

CNCR Tradability

3,370
$45.33K
2,650
$36.52K
0.69%
$0.09
-0.05%
1.95% / -2.87%
None
100.00%
50,000
0.05
0.01%
0.36%
0
$12.21
3

CNCR Sector/Industry Breakdown

CNCR Segment
Benchmark
99.98% --
0.01% --
0.00% --

CNCR Top 10 Holdings

6.05%
4.17%
42.35%

CNCR Performance Statistics

--
--
--
--
--
MSCI USA IMI / Pharmaceuticals Biotechnology & Life Sciences -IG

CNCR Countries

CNCR Segment
Benchmark
77.78% --
5.98% --
3.91% --
3.40% --
3.22% --
3.04% --
2.59% --

CNCR Regions

CNCR Segment
Benchmark
77.78% --
15.01% --
7.13% --

CNCR Economic Development

CNCR Segment
Benchmark
96.70% --
3.22% --

CNCR Benchmark Comparison Holdings

32
--
--
--

CNCR Benchmark Comparison Summary

CNCR Segment
Benchmark
32 --
$26.42B --
-11.46 --
2.96 --
0.32% --
Medium --

CNCR Benchmark Comparison Market Cap Size

CNCR Segment
Benchmark
29.34% --
6.98% --
59.72% --
2.38% --